BMOV ≥98%
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 10mg in glass bottle |
| 溶解性: | 溶于DMSO(5mg/ml 加热) |
| 产品描述: | 基本信息 产品编号: B60022 产品名称: BMOV CAS: 38213-69-3 储存条件 粉末 -20℃ 四年 分子式: C12H10O7V 溶于液体 -80℃ 两年 分子量 317.15 -20℃ 一个月 化学名: (SP-5-31)-bis(3-hydroxy-2-methyl-4H-pyran-4-onato-O3,O4)oxo-vanadium, Bis(maltolato)oxovanadium(IV) Solubility (25°C): 体外: DMSO 21mg/mL(66.21mM) Ethanol Insoluble Water Insoluble 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 制备储备液 浓度 溶液体积 质量 1mg 5mg 10mg 1mM 3.1531mL 15.7654mL 31.5308mL 5mM 0.6306mL 3.1531mL 6.3062mL 10mM 0.3153mL 1.5765mL 3.1531mL 50mM 0.0631mL 0.3153mL 0.6306mL 生物活性 产品描述 一种有效,可逆,竞争性和具有口服活性的光谱蛋白酪氨酸磷酸酶(PTP)抑制剂。是一种有效的胰岛素增敏剂。 靶点 IC50:126nM(HCPTPA),109nM(PTP1B),26nM(HPTPβ) and 201nM(SHP2) 体外研究 Bis(maltolato)oxovanadium(IV) treatment enhances the phosphorylation of the insulin receptor and of the insulin signalling key intermediate Akt. Bis(maltolato)oxovanadium(IV) (BMOV; 50μM) treatment also resultes in an increased glucose uptake in C2C12 cells 体内研究 Bis(maltolato)oxovanadium(IV) (BMOV; 0.75-3.0 mmol; intraperitoneal injection; twice weekly; for 6 weeks; C57BL/6J mice) treatment ameliorates the metabolic phenotype. Liver, skeletal muscle, and adipose tissue revealed a significantly reduced PTP activity in all analysed tissues compared to HFD mice Animal Model: C57BL/6J mice (4-6 weeks) fed with high-fat diet (HFD) Dosage: 0.75-3.0 mmol Administration: Intraperitoneal injection; twice weekly; for 6 weeks Result: Ameliorated the metabolic phenotype, as evidenced by reduced body weight, improved insulin sensitivity and glucose tolerance. |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

